Furthermore, a prior investigation in T-cell lymphoma cell lines found various differentially expressed genes and differently regulated pathways depending on the HD employed, lending credence to the idea that DNMT inhibitors have gene-specific effects [24,57]. This evidence concerns the gene DNMT1 and T-cell non-Hodgkin lymphoma.